Earlier this year, for a oncology-focused Institute for Value-Based Medicine® event, The American Journal of Managed Care® partnered with several prominent health care institutions from across the Nashville region to elevate value in cancer care by discussing the roles that […]
Elevating Cancer Care Through Personalized Treatment Read More »
The newest data on Rozanolixizumab (Rystiggo; UCB) show that this medication approved to treat adults with a specific form of generalized myasthenia gravis (gMG) continues to produce both overall symptom relief and targeted symptom relief for those with ocular impairment.
Rozanolixizumab Remains Consistently Safe, Effective for gMG Read More »
Out-of-specification (OOS) autologous chimeric antigen receptor (CAR) T-cell therapy was safely administered in patients in the UK who had relapsed/refractory large B-cell lymphoma (LBCL), potentially widening the pool of available treatments for these patients, despite initial manufacturing failure.1 Results recently
Overcoming CAR T Manufacturing Failure in LBCL Read More »
Many stories from the time around COVID-19 being declared a pandemic by the World Health Organization are of frontline health care workers constantly adjusting their treatment protocols. Studies are being published now about the pandemic’s impact on virtual care delivery,
Redefining Long COVID Care With Personalized Treatment Read More »
In early March, The American Journal of Managed Care® spoke with Andrew Kuykendall, MD, a clinical researcher at Moffitt Cancer Center who focuses on myeloproliferative neoplasms (MPNs), myelodysplastic syndrome/MPN overlap syndromes, and systemic mastocytosis. Kuykendall is an investigator on the
Understanding Hematocrit Thresholds in Polycythemia Vera Treatment Read More »
Editor’s note: An earlier version incorrectly referred to DEI instead of health equity. The ongoing call for research and studies to better reflect a real-world population has never been more important, with experts from across the medical community—from the psoriatic
Expanding Access to Clinical Trials Through Community Partnerships Read More »
Close monitoring and individualizing treatment plans should be top priorities for the multidisciplinary teams caring for women who are pregnant or are considering pregnancy and exhibiting signs of pulmonary hypertension, according to new research published in International Journal of Cardiology
Managing Pulmonary Hypertension in Pregnancy Read More »
New research out of England, which incorporated data from the National Health Service (NHS), shows that although socially disadvantaged areas have the greatest need for resources to diagnose, treat, and support patients who have long COVID, the gap in provision
Long COVID Disparities Revealed in New Study From England Read More »
The investigational allogeneic chimeric antigen receptor (CAR) T-cell therapy cemacabtagene ansegedleucel (cema-cel; Allogene Therapeutics) is being evaluated in the ALPHA (NCT03939026) and ALPHA2 (NCT04416984) trials for relapsed/refractory large B-cell lymphoma, a type of non-Hodgkin lymphoma, and in the ALPHA3 trial
Gene Editing for Safer CAR T-Cell Therapy in Large B-Cell Lymphoma Read More »
The 2025 Conference on Retroviruses and Opportunistic Infections (CROI) took place March 9 to 12 in San Francisco. Coverage included the latest developments in the HIV space for young and older patients—clinical trial developments, the newest drug data, and community-based
Community, Connection, and Sharing the Science at CROI 2025 Read More »
